Although EMMPRIN’s role in cancer and angiogenesis is well documented, its involvement in diabetic complications, particularly those involving abnormal angiogenesis like diabetic retinopathy, remains an area of active investigation [70]. This evidence concerns the gene BSG and diabetic retinopathy.